Asthma, eczema, and allergy (atopic diseases) are the first common chronic diseases to manifest during childhood. Approximately 20% of children develop asthma-like symptoms, and an estimated 300 million people suffer from asthma worldwide. A healthy embryo is considered essentially sterile and the first and very important colonization is established by it’s early contact with the environment. Therefore, the first years of our lives represent a critical period for susceptibility to environmental exposures – an open window – from which lasting effects can be imprinted on the developing immune system, which may in time lead to atopic disease. In collaboration with Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), we study how the microbiome is an intermediary player in the interaction between the host and its environment, with a key focus in research into the extrinsic mechanisms that determine the transition from health to chronic disease.
COPSAC2010 is an ongoing Danish cohort study of 738 unselected pregnant women and their 700 children followed from pregnancy week 24. The foundation of the project will be the vast amount of data from the COPSAC clinical birth cohort with extensive longitudinal microbial samples characterized by sequencing through the first year of life (1 week, 1 month, and 1 year), as well as later time points from. The primary endpoints: asthma, eczema and allergy have been diagnosed prospectively by the COPSAC pediatricians. The applicant will join the Section of Microbiology and with the microbial expertise of Professor Søren J. Sørensen’s lab, where the project will leverage a strong interdisciplinary research cooperation to pursue projects that:
- Investigate lifestyle changes and early life environmental exposures, which through gene-environment interactions are believed to cause immune deregulation, inflammation and subsequently symptomatic disease.
- Examine the correlation between the early-life gut microbiome and disease development, focusing on asthma, eczema and allergic sensitization to provide key information on the role of microbial interactions and identify microbial markers predisposing for either health or disease development.
For more information contact:
Urvish Trivedi, e-mail: email@example.com or
Søren Sørensen, e-mail: firstname.lastname@example.org
You are also very welcome to visit our homepage for more information on the Section of Microbiology: